HSP News Alert Hospira Inc (HSP) 62.60 12/25/2014 07:07:16

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hospira Inc (HSP) 62.60 $HSP

Hospira Shares Up 20.9% Since SmarTrend's Buy Recommendation (HSP)
Comtex SmarTrend(R) - Tue Dec 23, 5:05PM CST
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 2 months, Hospira has returned 20.89% as of today's recent price of $62.67.
HSP: 62.60 (-0.07)

Hospira to Present at the J.P. Morgan 33rd Annual Healthcare Conference Jan. 14, 2015
PR Newswire - Fri Dec 19, 3:30PM CST
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at the J.P. Morgan 33rd Annual Healthcare Conference on Wednesday, Jan. 14, 2015, in San Francisco.
JPM: 62.48 (unch), HSP: 62.60 (-0.07)

Is Boston Scientific (BSX) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 3:50PM CST
On Dec 16, 2014, Zacks Investment Research upgraded Boston Scientific Corporation (BSX) to a Zacks Rank #2 (Buy).
MGNX: 33.00 (+0.34), BSX: 13.13 (+0.07), ABAX: 58.48 (+0.22), HSP: 62.60 (-0.07)

Uptrend Call Working As Hospira Stock Rises 15.8% (HSP)
Comtex SmarTrend(R) - Tue Dec 16, 11:11AM CST
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 2 months, Hospira has returned 15.76% as of today's recent price of $60.01.
HSP: 62.60 (-0.07)


Family of executed Ohio inmate sues expert witness
By ANDREW WELSH-HUGGINS - AP - Tue Dec 16, 9:36AM CST
COLUMBUS, Ohio (AP) — The state's former expert witness on lethal injection should have known that a condemned inmate would suffer because of a two-drug combo that had never been used before, the inmate's family said in a lawsuit.
MCK: 209.79 (+0.58), HSP: 62.60 (-0.07)

2015 Healthcare Sector Predictions
Leonard Yaffe - Seeking Alpha - Tue Dec 16, 5:50AM CST
Below, I shall review my 2013 and 2014 predictions, as well as share my thoughts on the year ahead. Below are my 2014 Predictions: 1. An increase (however modest) of those without prior health insurance, combined with an improving economy, will...
HYH: 42.62 (-0.24), ABT: 45.70 (-0.02), BIIB: 340.89 (+5.13), MCK: 209.79 (+0.58), CAH: 82.07 (+0.15), DPLO: 29.90 (+0.49), PFE: 31.42 (-0.03), KMB: 117.77 (-0.21), HSP: 62.60 (-0.07), CELG: 109.60 (+3.48), JNJ: 104.59 (+0.31), GILD: 91.29 (+1.84), MRK: 57.46 (+0.25), CVS: 97.89 (+0.02), AGIO: 109.67 (+2.45), REGN: 400.12 (+6.07)

Hospira Rises 4.53% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Dec 11, 4:45PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $59.44 to a high of $63.08. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $61.30 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 62.60 (-0.07)

Hospira Set to Possibly Pullback After Yesterday's Rally of 4.53%
Comtex SmarTrend(R) - Thu Dec 11, 4:44PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $59.44 to a high of $63.08. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $61.30 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 62.60 (-0.07)

Update: Cubist Pharmaceuticals Is Acquired By Merck, Gains Remain For Investors
David Zanoni - at Seeking Alpha - Wed Dec 10, 11:31PM CST

CBST: 100.29 (-0.09), MRK: 57.46 (+0.25), HSP: 62.60 (-0.07)

Merck-Cubist Deal On Despite Patent Setback, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 3:30PM CST
Merck (MRK) intends to go ahead with the Cubist acquisition despite the recent unfavorable court ruling regarding Cubicin.
CBST: 100.29 (-0.09), MRK: 57.46 (+0.25), TEVA: 57.09 (+0.33), HSP: 62.60 (-0.07)

Merck-Cubist deal going ahead
at Investor's Business Daily - Tue Dec 09, 5:42PM CST
The $9.5 bil acquisition is advancing, even though Cubist Pharma's (CBST) lead drug may face generic competition sooner than expected. The companies announced the deal Mon., hours before a federal judge in Del. ruled as invalid 4 of 5 Cubist patents...
CBST: 100.29 (-0.09), MRK: 57.46 (+0.25), HSP: 62.60 (-0.07)

Cubist Shoots Up on $9.5 Billion Buyout Offer from Merck - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 3:30PM CST
Merck (MRK) is set to acquire Cubist in an all-cash transaction valued at about $9.5 billion or $102 per share which will strengthen its hospital acute care portfolio.
CBST: 100.29 (-0.09), MRK: 57.46 (+0.25), BIOD: 1.36 (-0.04), HSP: 62.60 (-0.07)

Merck-Cubist Deal Is On Despite Patent Setback
at Investor's Business Daily - Tue Dec 09, 10:27AM CST
Big pharma Merck affirmed Tuesday that it's going ahead with its $9.5 billion acquisition of biotech Cubist Pharmaceuticals even though Cubist's lead drug looks to face generic competition sooner than expected. Merck (MRK) stock was down 4.5% in...
CBST: 100.29 (-0.09), MRK: 57.46 (+0.25), MYL: 56.97 (+0.39), FMS: 37.40 (+0.15), TEVA: 57.09 (+0.33), HSP: 62.60 (-0.07)

Merck committed to Cubist after patent losses
By TOM MURPHY - AP - Tue Dec 09, 9:27AM CST
Merck remains committed to its $8.4 billion acquisition of Cubist Pharmaceuticals even though a federal court invalidated most of the patents protecting the company's top-selling antibiotic just hours after that deal was announced Monday.
CBST: 100.29 (-0.09), MRK: 57.46 (+0.25), TEVA: 57.09 (+0.33), HSP: 62.60 (-0.07)

Wall Street Breakfast: China Stocks Tumble Most Since 2009
Wall Street Breakfast - Seeking Alpha - Tue Dec 09, 5:31AM CST
Economy European stocks fell for a second day as German imports and exports contracted in October, while Tesco ( OTCPK:TSCDF , OTCPK:TSCDY ) and energy companies plunged. German October imports slid 3.1% from a month earlier, while exports...
AMZN: 303.03 (-3.26), DRC: 81.19 (-0.10), VRX: 140.33 (-0.22), TLM: 7.84 (unch), C: 54.54 (+0.12), DB: 30.95 (+0.04), FIVE: 38.76 (-0.11), HSP: 62.60 (-0.07), ARO: 2.30 (-0.03), AGN: 210.12 (+0.95), PBR: 7.60 (-0.11), SPY: 207.77 (+0.02), QQQ: 104.30 (+0.09), CBST: 100.29 (-0.09), SMFG: 7.29 (+0.03), BHP: 46.95 (-0.36), MRK: 57.46 (+0.25), HMC: 30.37 (+0.14)

16.0% Return Seen to Date on SmarTrend Hospira Call (HSP)
Comtex SmarTrend(R) - Mon Dec 08, 5:58PM CST
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 2 month, Hospira has returned 15.97% as of today's recent price of $60.12.
HSP: 62.60 (-0.07)

Merck, Cubist slip AH; Hospira gets favorable ruling
Seeking Alpha - at Seeking Alpha - Mon Dec 08, 5:11PM CST

CBST: 100.29 (-0.09), MRK: 57.46 (+0.25), HSP: 62.60 (-0.07)

You Can Outsmart Wall Street With These 3 Stocks
Motley Fool Staff - Motley Fool - Sat Dec 06, 11:32AM CST
Source: Flickr user snowlepard.  Many investors look to Wall Street for guidance when it comes to which stocks they should be buying and selling. But truth be told, Wall Street analysts are just as fallible as you and I. Many great companies often...
LUK: 22.44 (-0.27), BOH: 58.90 (-0.03), HSP: 62.60 (-0.07)

Meet 5 Top Drug Stocks That Are Bolting Past Market
at Investor's Business Daily - Tue Dec 02, 7:02AM CST
Celgene and Amgen are among the highly rated companies on IBD's Screen Of The Day, Bolting RS Lines. The Relative Strength line measures how a stock performs compared to the S&P 500 index. RS lines hitting new highs before the actual stock is a...
SHPG: 209.29 (+0.07), AZN: 70.44 (+0.26), AMGN: 160.67 (+3.15), AMAG: 43.02 (+0.90), ABBV: 66.21 (+1.86), HSP: 62.60 (-0.07), CELG: 109.60 (+3.48)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Great Rail Journeys Bets Bigger on Luxury Rail in 2027

Updated Category News Views 107

A $19,995 vacation is not selling a seat on a train; it is selling relief from planning, crowds and compromise. Great Rail Journeys is leaning hard into that proposition for 2027 with two additions to its premium Landmark Collection: a Europe-heavy Orient Express and Rhône cruise pairing, plus a South Africa itinerary built around safari, Victoria Falls and rail-flavored...

Continue Reading
Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 75

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 54

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 138

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 53

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 70

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 119

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Align Wagner Collection Tests Men's Footwear Depth

Updated Category News Views 57

Three pairs of shoes are not a revolution, but they can expose whether a young brand has its footing. Align, established in 2025 by H.H. Brown, is rolling out the Wagner collection for Fall-Winter 2026 with a waterproof boot, a penny loafer and a lace-up oxford. That is a sensible little arsenal, not some overstuffed catalog dreamed up by a marketing committee that has...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Microinsurance Market Expected to Surpass $11 Billion by 2034

Updated Category News Views 137

Growth Trajectory of the Global Microinsurance Market The microinsurance market is witnessing remarkable transformation as consumer demands shift towards financial inclusion, coupled with increasing awareness of the myriad advantages insurance provides. This positive trend is fueled by government initiatives aimed at regulation and expansion of microinsurance offerings,...

Continue Reading
Ormat Technologies Launches Secondary Stock Offering

Updated Category News Views 188

Ormat Technologies Launches Secondary Stock Offering Ormat Technologies, Inc. (NYSE: ORA), renowned for its innovative geothermal and renewable energy solutions, recently announced an exciting development in the investment realm—the initiation of an underwritten secondary offering. This offering encompasses a total of 3,700,000 shares of common stock on behalf of ORIX...

Continue Reading
MongoDB Executive Share Transactions Highlight Growth Potential

Updated Category News Views 132

Insights from MongoDB Executive Share Transactions Cochran Hope F, a director at MongoDB, Inc. (NASDAQ: MDB), recently made notable moves with the company's Class A Common Stock, and these transactions were disclosed in the latest SEC filings. This activity has attracted attention from investors. In September, the director sold 1,174 shares at $224.38 each, which brought...

Continue Reading
Essential Guidance for Navigating Hurricane Travel Risks

Updated Category News Views 69

Essential Guidance for Navigating Hurricane Travel Risks Hurricane season brings with it the potential for severe weather that can disrupt travel plans and lead to significant financial losses. As storms like Hurricane Helene have shown, the impact can be widespread, devastating homes and infrastructure, particularly in the southeastern regions. During these turbulent...

Continue Reading
Ascend Performance Materials Launches High-Purity Production

Updated Category News Views 279

Ascend Performance Materials Starts High-Purity Acrylonitrile Production Ascend Performance Materials has recently announced an exciting new phase in its production capabilities. The company is now producing high-purity acrylonitrile at its Chocolate Bayou facility. This advancement comes after the successful installation and commissioning of state-of-the-art purification...

Continue Reading